| Phytotherapy: A promising approach for the treatment of Alzheimer's disease OO John, IS Amarachi, AP Chinazom, E Adaeze, MB Kale, MD Umare, ... Pharmacological Research-Modern Chinese Medicine 2, 100030, 2022 | 53 | 2022 |
| Agmatine modulates anxiety and depression-like behaviour in diabetic insulin-resistant rats M Kale, N Nimje, MM Aglawe, M Umekar, B Taksande, N Kotagale Brain research 1747, 147045, 2020 | 46 | 2020 |
| Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach AB Upaganlawar, NL Wankhede, MB Kale, MD Umare, A Sehgal, S Singh, ... Biomedicine & Pharmacotherapy 143, 112146, 2021 | 44 | 2021 |
| Involvement of molecular chaperone in protein-misfolding brain diseases NL Wankhede, MB Kale, AB Upaganlawar, BG Taksande, MJ Umekar, ... Biomedicine & Pharmacotherapy 147, 112647, 2022 | 41 | 2022 |
| Agmatine improves the behavioral and cognitive impairments associated with chronic gestational ethanol exposure in rats MM Aglawe, MB Kale, SR Rahangdale, NR Kotagale, MJ Umekar, ... Brain research bulletin 167, 37-47, 2021 | 36 | 2021 |
| Alzheimer’s disease and sleep disorders: Insights into the possible disease connections and the potential therapeutic targets VS Marde, UA Atkare, SV Gawali, PL Tiwari, SP Badole, NL Wankhede, ... Asian Journal of Psychiatry 68, 102961, 2022 | 29 | 2022 |
| Interweaving of reactive oxygen species and major neurological and psychiatric disorders MD Umare, NL Wankhede, KK Bajaj, RV Trivedi, BG Taksande, ... Annales Pharmaceutiques Françaises 80 (4), 409-425, 2022 | 27 | 2022 |
| Neurodegenerative disorders associated with genes of mitochondria VS Marde, PL Tiwari, NL Wankhede, BG Taksande, AB Upaganlawar, ... Future Journal of Pharmaceutical Sciences 7, 1-8, 2021 | 23 | 2021 |
| Mitochondrial dysfunction as a signaling target for therapeutic intervention in major neurodegenerative disease SV Mangrulkar, NL Wankhede, MB Kale, AB Upaganlawar, BG Taksande, ... Neurotoxicity Research 41 (6), 708-729, 2023 | 19 | 2023 |
| 3D printing in pharmaceuticals: an emerging technology full of challenges K Wadher, R Trivedi, N Wankhede, M Kale, M Umekar Annales Pharmaceutiques Françaises 79 (2), 107-118, 2021 | 19 | 2021 |
| Mitophagy regulation in aging and neurodegenerative disease TA Banarase, SS Sammeta, NL Wankhede, SV Mangrulkar, ... Biophysical Reviews 15 (2), 239-255, 2023 | 13 | 2023 |
| Acute orexigenic effect of agmatine involves interaction between central α2-adrenergic and GABAergic receptors BG Taksande, O Sharma, MM Aglawe, MB Kale, DY Gawande, ... Biomedicine & Pharmacotherapy 93, 939-947, 2017 | 13 | 2017 |
| Exercise and nutraceuticals: eminent approach for diabetic neuropathy MB Kale, K Bajaj, M Umare, NL Wankhede, BG Taksande, MJ Umekar, ... Current Molecular Pharmacology 15 (1), 108-128, 2022 | 12 | 2022 |
| Molecular understanding of ER-MT communication dysfunction during neurodegeneration SS Sammeta, TA Banarase, SR Rahangdale, NL Wankhede, MM Aglawe, ... Mitochondrion, 2023 | 11 | 2023 |
| Agmatine as a Novel Intervention for Alzheimer's Disease: Pathological Insights and Cognitive Benefits RA Katariya, SS Sammeta, MB Kale, NR Kotagale, MJ Umekar, ... Ageing Research Reviews, 102269, 2024 | 8 | 2024 |
| Overview on the Polyphenol Avenanthramide in Oats (Avena sativa Linn.) as Regulators of PI3K Signaling in the Management of Neurodegenerative Diseases NL Wankhede, MB Kale, AK Bawankule, MM Aglawe, BG Taksande, ... Nutrients 15 (17), 3751, 2023 | 8 | 2023 |
| Mitochondrial Dysfunction in Ageing: Involvement of Oxidative Stress and Role of Melatonin MK Prerna Tiwari, Nitu Wankhede, Saurabh Badole, Mohit Umare, Brijesh ... Bulletin of Environment, Pharmacology and Life Sciences 10 ([2]), 156-172, 2021 | 8* | 2021 |
| AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling MB Kale, NL Wankhede, RS Pawar, S Ballal, R Kumawat, M Goswami, ... Ageing Research Reviews, 102497, 2024 | 7 | 2024 |
| Herbal medicine in the treatment of Alzheimer’s disease and Dementia: Phytoconstituent & their possible pharmacological activities SV Dabhekar, PA Chandurkar, MB Kale, NL Wankhede, BG Taksande, ... Depress Anxiety Open Access 5 (1), 1002, 2022 | 6 | 2022 |
| Leveraging AI for the diagnosis and treatment of autism spectrum disorder: current trends and future prospects NL Wankhede, MB Kale, M Shukla, D Nathiya, R Roopashree, P Kaur, ... Asian Journal of Psychiatry, 104241, 2024 | 5 | 2024 |
Prof. (Dr.) Milind UmekarSMT. KISHORITAI BHOYAR COLLEGE OF PHARMACY, KAMPTEE, NAGPUR, MAHARASHTRA, INDIAVerified email at skb.edu.in